|Articles|March 9, 2020

MassBio and Bayer Partner to Support Startup Community

MassBio and Bayer announced their partnership and launch of the Center for Regulatory Excellence, a forum for startups and academia to interact with and learn from regulatory experts. The Center will host regular seminars that will be open to all startups in the biotech and digital health space. Each session will focus on specific areas of interest related to the regulatory process and will entail lectures, open dialogue, and networking. 

To start, just Bayer will be providing the mentorship, but that may expand. However, the seminars are open to all startups, not just Bayer/MassCONNECT.


Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.